Biotage AB (publ)
Biotage AB (publ) (BITGF) Revenue
Annual & quarterly revenue history · segment & region breakdown
BITGF · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsBiotage AB (publ) trailing twelve-month (TTM) revenue is $1.96B, an increase of 10.42% year-over-year from $2.06B in FY2024.
Revenue trend
2024 – 2005 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2024-12-31 | $2.06B | +$0.19B | +10.42% |
| 2023-12-31 | $1.86B | +$0.30B | +18.90% |
| 2022-12-31 | $1.57B | +$0.33B | +27.11% |
| 2021-12-31 | $1.23B | +$0.14B | +12.82% |
| 2020-12-31 | $1.09B | -$0.01B | -0.85% |
| 2019-12-31 | $1.10B | +$0.19B | +20.91% |
| 2018-12-31 | $0.91B | +$0.16B | +21.75% |
| 2017-12-31 | $0.75B | +$0.08B | +12.01% |
| 2016-12-31 | $0.67B | +$0.06B | +9.40% |
| 2015-12-31 | $0.61B | +$0.12B | +24.50% |
Compare revenue vs peers
Medical - Instruments & SuppliesCompare BITGF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Biotage AB (publ) receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Biotage AB (publ) reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in SEK.
Data sourced from Biotage AB (publ)'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BITGF revenue · 4 questionsBITGF's trailing twelve-month (TTM) revenue is $1.96B. That is an increase of 10.42% year-over-year from $2.06B in FY2024.
▸ Source: FMP · Biotage AB (publ) SEC filings · GAAP · Biotage AB (publ) SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026